SB
Sabra Health Care REIT, Inc.
SBRA · NASDAQ
$20.78 +0.00% (+$0.00)
1M -1.24%
Market Cap $5.28B
P/E Ratio 80.66x
Div. Yield 5.73%
ROE 2.34%
Bulios Fair Price
$27.59
32.8% upside
Current Price
$20.78
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SBRA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
84 /100
Cheap P/S 6.14x
P/B 1.92x
P/FCF 15.24x
Growth
51 /100
Stable Rev. growth 7.43%
FCF growth 3.36%
Book val. growth 2.63%
Profitability
62 /100
Moderate Gross margin 72.58%
Net margin 7.61%
Op. margin 11.84%
Quality
23 /100
Poor ROIC 1.85%
ROE 2.34%
ROA 1.19%
Debt
73 /100
Low Debt/Equity 0.96x
Current ratio 43.68x
Int. coverage 1.69x
Stability
63 /100
Moderate Beta 0.64x
Rev. volatility 3.41%
EPS volatility 433.39%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SBRA
Online
Sector
Real Estate
Industry
REIT - Healthcare Facilities
CEO
Richard K. Matros
Employees
58
Headquarters
Tustin
Upcoming events
04 NOV
Earnings
Upcoming earnings report